Antifungal immunity in Hirschsprung-Associated Enterocolitis
先天性巨结肠相关小肠结肠炎的抗真菌免疫
基本信息
- 批准号:9883716
- 负责人:
- 金额:$ 25.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-03-01 至 2022-02-28
- 项目状态:已结题
- 来源:
- 关键词:AnimalsAntibodiesAntibody titer measurementAntifungal AgentsAutomobile DrivingC Type Lectin ReceptorsCandidaCandida albicansCandida utilisCessation of lifeChildColitisComplicationCongenital MegacolonDataDevelopmentDiagnosisDiseaseEarly identificationEnterocolitisFecesFutureGenesGenetic PolymorphismGenetic Predisposition to DiseaseHospitalizationImmune responseImmunityImmunologic ReceptorsInflammatory Bowel DiseasesIntestinesInvestigationKnockout MiceLeadLinkMethodsModelingMusMutant Strains MiceOperative Surgical ProceduresPatientsPopulationPredispositionPreventionReceptor SignalingReportingRhodotorulaRiskRisk FactorsRoleSNP genotypingSaccharomyces cerevisiaeSeveritiesSeverity of illnessSignaling MoleculeSingle Nucleotide Polymorphismcohortdectin 1dysbiosisfungusgut colonizationgut microbiotahigh riskinflammatory disease of the intestineinterestloss of functionmicrobiome researchmouse modelmutantnovelnovel strategiespathogenic funguspersonalized approach
项目摘要
PROJECT SUMMARY
Hirschsprung associated enterocolitis (HAEC) is the most frequent complication in children with Hirschsprung
disease (HSCR), resulting in frequent hospitalizations and half of deaths in this population. The mechanisms
underlying HAEC are poorly understood. We reported in a microbiome study that Candida spp. are specifically
enriched in stool of HAEC patients, and we report here that HAEC patients have elevated anti-Saccharomyces
cerevisiae antibody (ASCA) titers. Since ASCA levels are known to be associated with inflammatory bowel
disease (IBD), we hypothesized that other risk factors for IBD might be associated with HAEC. We genotyped
single nucleotide polymorphisms (SNPs) in a small cohort of HSCR patients and found preliminary evidence
that 37 SNPs previously found to associate with IBD may also be linked to the risk of developing HAEC. One of
these genes, CARD9, particularly caught our interest because CARD9 is involved in host immune responses to
intestinal microbes, especially fungi, as a signaling molecule involved in anti-fungal C-type lectin receptor
signaling. We have established a mouse model of HAEC (Ednrb-null mouse model) and found that creating
Ednrb-Clec7a double mutant mice (Clec7a gene encodes for the antifungal C-type lectin receptor Dectin-1)
causes a 5-fold increase in fecal C. albicans and 4-fold increased enterocolitis severity compared with controls.
We further observed in the Ednrb-null model that natural intestinal colonization with Candida utilis and
Rhodotorula mucilaginosa is associated with the risk of developing HAEC. Finally, HAEC severity was reduced
65% when animals were treated with the antifungal drug isavuconazole. Together, these discoveries suggest
new mechanisms for HAEC implicating intestinal fungi and antifungal immunity. Our overall hypothesis is that
HSCR patients with genetic susceptibility to developing HAEC respond inappropriately to changes in the
intestinal microbiota, (with a particular interest in fungi) leading to a difficult-to-treat colitis. This hypothesis will
be investigated in the following two aims: 1) investigate the role of antifungal immunity gene Card9 in a mouse
model of HAEC; 2) define the role of Candida utilis and Rhodotorula mucilaginosa in the same mouse model of
HAEC. The line of investigation outlined here may lead to greater rationale for treating HAEC patients using
personalized approaches and may lead to methods for early identification of patients at high risk of developing
HAEC.
项目总结
先天性巨结肠炎(HAEC)是先天性巨结肠患儿最常见的并发症
疾病(HSCR),导致该人群频繁住院和一半的死亡。其作用机制
人们对潜在的HAEC知之甚少。我们在微生物组研究中报道了假丝酵母菌。都是特别的
在HAEC患者的粪便中富含,我们在这里报告HAEC患者的抗酵母菌升高。
酿酒酵母抗体(ASCA)效价。由于已知ASCA水平与肠炎有关
疾病(IBD),我们假设IBD的其他危险因素可能与HAEC相关。我们进行了基因分型
一小部分HSCR患者的单核苷酸多态(SNPs)研究及初步证据
先前发现的与IBD相关的37个SNP也可能与发生HAEC的风险有关。其中之一
这些基因,CARD9,尤其引起了我们的兴趣,因为CARD9参与了宿主对
肠道微生物,特别是真菌,作为信号分子参与抗真菌C型凝集素受体
发信号。我们已经建立了HAEC的小鼠模型(EDNRB-Null小鼠模型),发现创建
EDNRB-Clec7a双突变小鼠(Clec7a基因编码抗真菌C型凝集素受体Dectin-1)
导致与对照组相比,粪便中白色念珠菌的数量增加了5倍,小肠结肠炎的严重性增加了4倍。
我们进一步在EDNRB零模型中观察到,念珠菌和白念珠菌的自然肠道定植
粘红酵母与HAEC的发病风险相关。最后,HAEC的严重程度降低了
当动物接受抗真菌药物异伍康唑治疗时,65%的人感染。总而言之,这些发现表明
HAEC参与肠道真菌和抗真菌免疫的新机制。我们的总体假设是
对发生HAEC有遗传易感性的HSCR患者对
肠道微生物区系(对真菌特别感兴趣),导致难以治疗的结肠炎。这一假说将
1)研究抗真菌免疫基因CARD9在小鼠体内的作用
2)确定念珠菌和粘性红酵母在同一小鼠HAEC模型中的作用
HAEC。这里概述的调查路线可能会导致更多的理由来治疗HAEC患者使用
个性化的方法,并可能导致早期识别高危患者的方法
HAEC。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Philip Kent Frykman其他文献
Philip Kent Frykman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Philip Kent Frykman', 18)}}的其他基金
Bacterial and Fungal Dysbiosis in Hirschsprung-Associated Enterocolitis
先天性巨结肠相关小肠结肠炎的细菌和真菌失调
- 批准号:
9263941 - 财政年份:2016
- 资助金额:
$ 25.5万 - 项目类别:
ET3-EDNRB Signaling in Enterocolitis Associated with Colonic Aganglionosis
与结肠无神经节病相关的小肠结肠炎中的 ET3-EDNRB 信号转导
- 批准号:
8262153 - 财政年份:2011
- 资助金额:
$ 25.5万 - 项目类别:
ET3-EDNRB Signaling in Enterocolitis Associated with Colonic Aganglionosis
与结肠无神经节病相关的小肠结肠炎中的 ET3-EDNRB 信号转导
- 批准号:
8460035 - 财政年份:2011
- 资助金额:
$ 25.5万 - 项目类别:
ET3-EDNRB Signaling in Enterocolitis Associated with Colonic Aganglionosis
与结肠无神经节病相关的小肠结肠炎中的 ET3-EDNRB 信号转导
- 批准号:
8030412 - 财政年份:2011
- 资助金额:
$ 25.5万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 25.5万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 25.5万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 25.5万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 25.5万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 25.5万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 25.5万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 25.5万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 25.5万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 25.5万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 25.5万 - 项目类别: